Last reviewed · How we verify

infiltration of corticosteroids

Centre Hospitalier Departemental Vendee · FDA-approved active Small molecule

Corticosteroid infiltration delivers anti-inflammatory glucocorticoids directly into affected tissues to suppress local immune responses and reduce inflammation.

Corticosteroid infiltration delivers anti-inflammatory glucocorticoids directly into affected tissues to suppress local immune responses and reduce inflammation. Used for Local inflammation and pain in joints, Soft tissue inflammation, Localized dermatological conditions.

At a glance

Generic nameinfiltration of corticosteroids
SponsorCentre Hospitalier Departemental Vendee
Drug classCorticosteroid
TargetGlucocorticoid receptor
ModalitySmall molecule
Therapeutic areaImmunology, Rheumatology, Dermatology
PhaseFDA-approved

Mechanism of action

Infiltration (local injection) of corticosteroids provides targeted delivery of glucocorticoids to specific anatomical sites, such as joints, soft tissues, or lesions. The corticosteroids bind to glucocorticoid receptors in local immune cells, suppressing cytokine production, reducing vasodilation, and decreasing inflammatory cell infiltration. This localized approach minimizes systemic exposure while achieving high local concentrations at the site of inflammation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: